These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7646343)

  • 1. Influence of tyrosine residues Y705 and Y807 on the transforming potency of the v-fms oncogene product of feline sarcoma virus.
    Trouliaris S; Hadwiger-Fangmeier A; Heimann M; Tamura T
    Arch Virol; 1995; 140(1):179-86. PubMed ID: 7646343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine 807 of the v-Fms oncogene product controls cell morphology and association with p120RasGAP.
    Trouliaris S; Smola U; Chang JH; Parsons SJ; Niemann H; Tamura T
    J Virol; 1995 Oct; 69(10):6010-20. PubMed ID: 7666506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of a transformation-defective mutant of the McDonough strain of feline sarcoma virus exhibiting tyrosine kinase activity in vitro but not in vivo.
    Tamura T; Hennig D; Grell M; Niemann H; Boschek B
    J Virol; 1988 Jun; 62(6):2150-7. PubMed ID: 2835515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transformation of chicken fibroblasts by the v-fms oncogene.
    Tamura T; Hadwiger-Fangmeier A; Boschek B; Niemann H
    Virology; 1990 Oct; 178(2):401-9. PubMed ID: 2171188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming mechanism of the feline sarcoma virus encoded v-fms oncogene product.
    Tamura T; Hadwiger-Fangmeier A; Simon E; Smola U; Geschwill H; Schütz B; Trouliaris S; Boscheck B; Niemann H; Bauer H
    Behring Inst Mitt; 1991 Jul; (89):93-9. PubMed ID: 1834054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor (EGF) modulation of feline sarcoma virus fms tyrosine kinase activity, internalization, degradation, and transforming potential in an EGF receptor/v-fms chimera.
    Riedel H
    J Virol; 1994 Jan; 68(1):411-24. PubMed ID: 8254751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The amino-terminal domain of the v-fms oncogene product includes a functional signal peptide that directs synthesis of a transforming glycoprotein in the absence of feline leukemia virus gag sequences.
    Wheeler EF; Roussel MF; Hampe A; Walker MH; Fried VA; Look AT; Rettenmier CW; Sherr CJ
    J Virol; 1986 Aug; 59(2):224-33. PubMed ID: 3525854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reassessment of the v-fms sequence: threonine phosphorylation of the COOH-terminal domain.
    Smola U; Hennig D; Hadwiger-Fangmeier A; Schütz B; Pfaff E; Niemann H; Tamura T
    J Virol; 1991 Nov; 65(11):6181-7. PubMed ID: 1833563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of functional domains of the v-fms-encoded protein of Susan McDonough strain feline sarcoma virus by linker insertion mutagenesis.
    Lyman SD; Rohrschneider LR
    Mol Cell Biol; 1987 Sep; 7(9):3287-96. PubMed ID: 2823125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. gp140v-fms molecules expressed at the surface of cells transformed by the McDonough strain of feline sarcoma virus are phosphorylated in tyrosine and serine.
    Tamura T; Simon E; Niemann H; Snoek GT; Bauer H
    Mol Cell Biol; 1986 Dec; 6(12):4745-8. PubMed ID: 2432405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation by Gi2 proteins of v-fms-induced proliferation and transformation via Src-kinase and STAT3.
    Corre I; Baumann H; Hermouet S
    Oncogene; 1999 Nov; 18(46):6335-42. PubMed ID: 10597233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific binding of the mononuclear phagocyte colony-stimulating factor CSF-1 to the product of the v-fms oncogene.
    Sacca R; Stanley ER; Sherr CJ; Rettenmier CW
    Proc Natl Acad Sci U S A; 1986 May; 83(10):3331-5. PubMed ID: 3010289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies to the transformation-specific glycoprotein encoded by the feline retroviral oncogene v-fms.
    Anderson SJ; Furth M; Wolff L; Ruscetti SK; Sherr CJ
    J Virol; 1982 Nov; 44(2):696-702. PubMed ID: 6292527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a second Grb2 binding site in the v-Fms tyrosine kinase.
    Mancini A; Niedenthal R; Joos H; Koch A; Trouliaris S; Niemann H; Tamura T
    Oncogene; 1997 Sep; 15(13):1565-72. PubMed ID: 9380408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The v-fms oncogene induces factor independence and tumorigenicity in CSF-1 dependent macrophage cell line.
    Wheeler EF; Rettenmier CW; Look AT; Sherr CJ
    Nature; 1986 Nov 27-Dec 3; 324(6095):377-80. PubMed ID: 3024013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene products of McDonough feline sarcoma virus have an in vitro-associated protein kinase that phosphorylates tyrosine residues: lack of detection of this enzymatic activity in vivo.
    Barbacid M; Lauver AV
    J Virol; 1981 Dec; 40(3):812-21. PubMed ID: 6275118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transformation by the oncogene v-fms: the effects of castanospermine on transformation-related parameters.
    Nichols EJ; Manger R; Hakomori SI; Rohrschneider LR
    Exp Cell Res; 1987 Dec; 173(2):486-95. PubMed ID: 2826191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transformation by the v-fms oncogene product: role of glycosylational processing and cell surface expression.
    Nichols EJ; Manger R; Hakomori S; Herscovics A; Rohrschneider LR
    Mol Cell Biol; 1985 Dec; 5(12):3467-75. PubMed ID: 3018522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The kinase activity of the v-fms encoded protein has a low pH optimum.
    Lyman SD; Rohrschneider LR
    Oncogene Res; 1989; 4(2):149-55. PubMed ID: 2654815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in mechanisms of transformation by independent feline sarcoma virus isolates.
    Reynolds FH; Van de Ven WJ; Blomberg J; Stephenson JR
    J Virol; 1981 Jun; 38(3):1084-9. PubMed ID: 6165838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.